Neurodegeneration: Brain Activity in Parkinson’s Disease

Parkinson’s disease (PD) is a progressive neurological disorder affecting millions worldwide.

While the disease’s hallmark symptoms include tremors, muscle rigidity, and slowness of movement, the root cause lies in the brain.

In this blog post, we’ll dive into how brain activity changes in Parkinson’s, explore the functional brain networks involved, and look at how these insights guide current treatments and future research.

The Role of the Brain in Parkinson’s Disease

Parkinson’s disease primarily targets the brain’s ability to control movement.

It arises due to the loss of dopamine-producing neurons in a part of the brain known as the substantia nigra.

Dopamine is a chemical messenger that plays a key role in sending signals between the brain and the body to coordinate movement.

As these dopamine levels decrease, the brain struggles to communicate effectively with the muscles, leading to the common motor symptoms of PD.

But it’s not just the motor areas that are affected.

Cognitive and emotional changes can also occur, often resulting in depression, anxiety, and cognitive impairment.

Abnormal Brain Activity in Parkinson’s Disease

In Parkinson’s, the loss of dopamine creates a ripple effect, disrupting the normal firing of neurons in the brain.

Studies using imaging technologies like functional MRI (fMRI) and positron emission tomography (PET) have shown abnormal patterns of brain activity in PD patients.

Specifically, the basal ganglia, a group of structures that work with the substantia nigra to regulate movement, become overactive or underactive depending on the stage of the disease.

Hyperactivity and hypoactivity in brain regions

Research has shown that areas such as the globus pallidus internus and the subthalamic nucleus become hyperactive, leading to motor symptoms like rigidity and tremors.

At the same time, hypoactivity in the motor cortex results in slower movements, or bradykinesia.

In addition to motor areas, the prefrontal cortex, responsible for cognitive functions like planning and decision-making, is also affected.

This helps explain why up to 50% of people with Parkinson’s may develop some form of cognitive impairment during the course of their disease.

Functional Brain Networks in Parkinson’s Disease

Parkinson’s disease is not just a localized issue; it’s a network disorder.

Brain regions communicate through complex pathways called functional networks.

The disruption of these networks helps explain both motor and non-motor symptoms of Parkinson’s.

Default mode network (DMN)

One important network is the Default Mode Network (DMN), which becomes active when the brain is at rest and not focused on the outside world.

In people with Parkinson’s, studies show decreased connectivity in the DMN.

This disruption has been linked to the cognitive impairments and memory problems often observed in PD patients.

Motor networks

The corticostriatal circuit is another key player.

It involves communication between the cortex and the striatum (part of the basal ganglia), which is crucial for initiating and controlling movement.

When dopamine is reduced, this circuit malfunctions, contributing to the motor symptoms of PD.

Limbic system

The limbic system, which controls emotions, is also impacted.

This leads to the emotional symptoms often experienced by PD patients, such as depression and anxiety.

The interplay between these brain networks shows how interconnected movement, cognition, and emotion are in Parkinson’s disease.

Treatment and Research Implications

Understanding how Parkinson’s disease alters brain activity has been instrumental in shaping current treatments and ongoing research.

Medications

Most treatments for Parkinson’s focus on replenishing dopamine or mimicking its effects.

Levodopa, the most commonly prescribed drug, helps to temporarily restore dopamine levels, improving motor symptoms.

However, it doesn’t address the underlying brain network dysfunctions and becomes less effective as the disease progresses.

Deep brain stimulation (DBS)

Deep Brain Stimulation (DBS) is another advanced treatment that has emerged from our understanding of abnormal brain activity in PD.

In this procedure, electrodes are implanted in specific brain areas (usually the subthalamic nucleus or globus pallidus) to regulate abnormal firing patterns.

Studies show that DBS can improve motor symptoms significantly and even help reduce the need for medication.

Cutting-edge research

Ongoing research is exploring how to target not just dopamine loss but also the broader brain network disruptions seen in Parkinson’s.

Techniques like transcranial magnetic stimulation (TMS) and focused ultrasound are being tested to see if they can help “reset” these networks and offer more comprehensive relief from both motor and non-motor symptoms.

Final Thoughts

Parkinson’s disease is a complex disorder that affects more than just movement.

The brain’s activity is disrupted on multiple levels, from individual neurons to larger functional networks, leading to a wide range of symptoms.

Current treatments are effective to a point, but ongoing research is looking at new ways to address these network-wide disruptions and offer better outcomes for people with Parkinson’s.

FAQs